Based on this background and thanks to the availability of a new test on DBS to screen for LAL deficiency, blood LAL activity has been recently explored in different cohorts of patients with NAFLD and post-NASH cirrhosis, where it was generally found to be reduced [6–10]. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatohepatitis.